James Lah is a Neurology physician affiliated with Emory Healthcare. OpenAlex indexes 606 publications with 46,422 citations (h-index 101); ClinicalTrials.gov lists 1 registered study matched to this name. By OpenAlex citation count, this profile ranks in the top 5% of Neurology profiles in the findmyKOL directory.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
12 Executive Park Dr NE
Atlanta, GA 303292206
Telephone
404-778-3444Registry record last updated 22 Feb 2018.
Clinical trials
- Georgia Memory Net Anti-Amyloid Monoclonal Antibody Registry
Sponsor: Emory University
- Stimulating Neural Activity to Improve Blood Flow and Reduce Amyloid: Path to Clinical Trials
Sponsor: Emory University
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
3 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Lilly USA, LLCProgram year20252 payments
- Roche Diagnostics CorporationProgram year20221 payment
- Eisai Inc.Program year20221 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Nervous system
100%Cholinesterase Inhibitor42.5%Donepezil Hcl76%Galantamine Er13%Rivastigmine12%Part D<11 patientsSSRI26.4%Sertraline Hcl51%Escitalopram Oxalate37%Trazodone Hcl12%Part D<11 patients+ 4 more classes in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
7 NIH research awards on record, funded 1996–2026 per NIH RePORTER. The latest:
- Explainable and Ethical AI for Studying Alzheimer's Disease
Emory University
FY2026$679,906R01AG089806 - The Emory Healthy Brain Study: Discovering Predictive Biomarkers for Alzheimer's Disease
Emory University
FY2025$6,871,445R01AG070937
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
Similar KOLs
Other experts from the same institution or the same specialty.
Allan Levey, MD, PhD
Emory Healthcare
William Blum, MD
Emory Healthcare
Mehmet Bilen, MD
Emory Healthcare
Bradley Leshnower, MD
Emory Healthcare
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”